IRVINE, Calif., Feb. 10, 2015 /PRNewswire/ -- Edwards
Lifesciences Corporation (NYSE: EW), the global leader in the
science of heart valves and hemodynamic monitoring, today announced
two changes to the company's board of directors. Kieran T. Gallahue, chairman and chief executive
officer of CareFusion Corporation, has been appointed to Edwards'
board, effective immediately. Current director Mike R. Bowlin has expressed his desire to
retire from the board and will not seek re-election at the annual
stockholder meeting in May.
"We are fortunate that the timing of these individual decisions
enables Edwards to allow a smooth transition and benefit from both
Mike and Kieran during the next several months, working in
partnership with our talented board," said Michael A. Mussallem, Edwards' chairman and
CEO.
Bowlin joined Edwards' board of directors in 2000, when Edwards
was established as an independent, publicly held corporation. He
has served as a member and chairman of the compensation and
governance committee and presiding director. Bowlin retired
from the Atlantic Richfield Company in 2000, after holding
positions including chairman of the board, CEO and president.
"I'd like to take this opportunity to express my sincere
gratitude to Mike for his outstanding service to our board of
directors," said Mussallem. "He is extremely knowledgeable about
the complex international business environment and brought
large-scale experience on diverse compensation and incentive
matters. We wish Mike the best in his upcoming retirement from the
board, and thank him for his valuable insight and guidance as we
have built a record of success for Edwards.
"I would also like to welcome Kieran to a strong board that will
benefit from his 20 years of executive management experience in
medical technology and his leadership roles on other public company
boards and committees," said Mussallem. "Kieran has led a number of
innovative companies and been an active advocate of the value of
medical technology, and we look forward to his contributions in
helping to advise Edwards as we pursue our unique focused
innovation strategy."
Since 2011, Gallahue has served as chairman and CEO of
CareFusion, a global corporation serving the healthcare industry
with products and services that help hospitals measurably improve
the safety and quality of care. Prior, he served as president
and, later, as CEO of ResMed, Inc. Gallahue is currently on
the executive committee of the board of the Advanced Medical
Technology Association (AdvaMed).
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart
valves and hemodynamic monitoring. Driven by a passion to help
patients, the company partners with clinicians to develop
innovative technologies in the areas of structural heart disease
and critical care monitoring, enabling them to save and enhance
lives. Additional company information can be found at
edwards.com.
Edwards, Edwards Lifesciences and the stylized E logo are
trademarks of Edwards Lifesciences Corporation.
Logo -
http://photos.prnewswire.com/prnh/20140714/126903
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/edwards-announces-board-changes-300033339.html
SOURCE Edwards Lifesciences Corporation